Development of a hybrid alphavirus-SARS-CoV-2 pseudovirion for rapid quantification of neutralization antibodies and antiviral drugs

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike protein (S)-pseudotyped viruses are commonly used for quantifying antiviral drugs and neutralizing antibodies. Here, we describe the development of a hybrid alphavirus-SARS-CoV-2 (Ha-CoV-2) pseudovirion, which is a non-replicating SA...

Descripción completa

Detalles Bibliográficos
Autores principales: Hetrick, Brian, Chilin, Linda D., He, Sijia, Dabbagh, Deemah, Alem, Farhang, Narayanan, Aarthi, Luchini, Alessandra, Li, Tuanjie, Liu, Xuefeng, Copeland, Joshua, Pak, Angela, Cunningham, Tshaka, Liotta, Lance, Petricoin, Emanuel F., Andalibi, Ali, Wu, Yuntao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8866097/
https://www.ncbi.nlm.nih.gov/pubmed/35229082
http://dx.doi.org/10.1016/j.crmeth.2022.100181

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8866097/
https://www.ncbi.nlm.nih.gov/pubmed/35229082
http://dx.doi.org/10.1016/j.crmeth.2022.100181

Ejemplares similares